Sutro Biopharma Working Capital to Net Assets Ratio
Sutro Biopharma working capital to net assets ratio. Sutro Biopharma (STRO) has a Working Capital to Net Assets ratio of -118.8% as of June 2026. Working capital of $122.75 Million (current assets of $175.65 Million minus current liabilities of $52.90 Million) is measured against net assets of $-103.32 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Sutro Biopharma (STRO) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Sutro Biopharma (2016–2025)
Working capital to net assets ratio of Sutro Biopharma from 2016 to 2025. This chart shows how Sutro Biopharma's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at -118.8%, reflecting working capital of $122.75 Million against net assets of $-103.32 Million USD. See Sutro Biopharma defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Sutro Biopharma Working Capital to Net Assets Ratio by Year (2016–2025)
Sutro Biopharma working capital to net assets ratio by year from 2016 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Sutro Biopharma from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see STRO total asset value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -57.2% | $75.79 Million | $-132.45 Million | $150.93 Million | $75.13 Million | ▼ -531.2 pp |
| 2024 | 474.0% | $211.42 Million | $44.60 Million | $343.31 Million | $131.89 Million | ▲ +255.0 pp |
| 2023 | 219.0% | $327.80 Million | $149.65 Million | $421.54 Million | $93.75 Million | ▲ +87.0 pp |
| 2022 | 132.0% | $286.61 Million | $217.05 Million | $353.15 Million | $66.55 Million | ▲ +62.1 pp |
| 2021 | 70.0% | $176.78 Million | $252.56 Million | $218.51 Million | $41.74 Million | ▼ -35.0 pp |
| 2020 | 105.0% | $348.58 Million | $332.05 Million | $378.18 Million | $29.60 Million | ▲ +7.2 pp |
| 2019 | 97.8% | $95.60 Million | $97.79 Million | $128.57 Million | $32.97 Million | ▼ -34.2 pp |
| 2018 | 131.9% | $173.52 Million | $131.54 Million | $209.95 Million | $36.42 Million | ▲ +126.1 pp |
| 2017 | 5.8% | $-6.33 Million | $-109.00 Million | $25.63 Million | $31.96 Million | ▲ +5.3 pp |
| 2016 | 0.5% | $-493.00K | $-90.90 Million | $49.69 Million | $50.18 Million | — |